A Moral or Medical Problem? The Relationship between Legal Penalties and Treatment Practices for Opioid Use Disorders in Pregnant Women

Women's Health Issues

Volumn 26, Issue 6, 2016, Pages 595-601

  Angelotta, Cara ^a   Weiss, Carol J ^b   Angelotta, John W ^c   Friedman, Richard A ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Private Practice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADOLESCENT; ADULT; CHILD; CONFERENCE PAPER; CRIMINAL JUSTICE; DRUG DEPENDENCE TREATMENT; DRUG EFFECT; FEMALE; FUNDING; GEOGRAPHIC DISTRIBUTION; HUMAN; LAW; MAJOR CLINICAL STUDY; MEDICAID; MORALITY; OPIATE ADDICTION; PREGNANT WOMAN; PUNISHMENT; WOMEN'S HEALTH; YOUNG ADULT; CHILD ABUSE; INFANT; LEGISLATION AND JURISPRUDENCE; PREGNANCY; PREGNANCY COMPLICATION; PRESCHOOL CHILD; PSYCHOLOGY; UNITED STATES;

ADULT; CHILD ABUSE; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MEDICAID; MORALS; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANT WOMEN; UNITED STATES; YOUNG ADULT;

EID: 84994440889     PISSN: 10493867     EISSN: 18784321     Source Type: Journal    
DOI: 10.1016/j.whi.2016.09.002     Document Type: Conference Paper

References (44)

1. American Academy of Pediatrics, Committee on Substance Abuse. Drug-exposed infants. Pediatrics 96:2 (1995), 364–367.
2. American College of Obstetricians and Gynecologists (ACOG). ACOG committee opinion no 473. Substance abuse reporting and pregnancy: the role of the obstetrician–gynecologist. Obstetrics and Gynecology 117:1 (2011), 200–201.
3. American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women and American Society of Addiction Medicine. Committee opinion no 524. Opioid abuse, dependence, and addiction in pregnancy. Obstetrics and Gynecology 119:5 (2012), 1070–1076.
4. American Medical Association. Legal interventions during pregnancy: Court-ordered medical treatments and legal penalties for potentially harmful behavior by pregnant women. Journal of the American Medical Association 264:20 (1990), 2663–2670.
5. American Psychiatric Association. Position statement on the care of pregnant and newly delivered women addicts. American Journal of Psychiatry, 149(5), 1992 724–724.
6. American Society of Addiction Medicine. National practice guideline for the use of medications in the treatment of addiction involving opioid use. 2015 Available: www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline-supplement.pdf?sfvrsn=24 Accessed: April 11, 2016.
7. Ankrom v. State, 143 Si,3d 58 (Ala. 2013).
8. Centers for Disease Control and Prevention (CDC). Prescription painkiller overdoses. 2013 Available: www.cdc.gov/vitalsigns/prescriptionpainkilleroverdoses Accessed: March 3, 2015.
9. Chasnoff, I.J., Landress, H.J., Barrett, M.E., The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. New England Journal of Medicine 322:17 (1990), 1202–1206.
10. Eckholm, E. (2014). Specialists join call for veto of drug bill. The New York Times. Available: www.nytimes.com/2014/04/15/us/politics/specialists-join-call-for-veto-of-drug-bill.html. Accessed: March 31, 2015.
11. Fajemirokun-Odudeyi, O., Sinha, C., Tutty, S., Pairaudeau, P., Armstrong, D., Phillips, T., Lindow, S.W., Pregnancy outcome in women who use opiates. European Journal of Obstetrics and Gynecology and Reproductive Biology 126:2 (2006), 170–175.
12. Friedmann, P.D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K.,.. Frisman, L.K., Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions. Substance Abuse 33:1 (2012), 9–18.
13. Garson, G. D. (2016). Logistic regression: Binary & multinomial (Location 4765-4794). Statistical Publishing Associates, Asheboro, North Carolina.
14. Goodwin, M., Fetal protection laws: Moral panic and the new constitutional battlefront. California Law Review, 102(4), 2014.
15. Guttmacher Institute. Substance abuse during pregnancy. 2015 Available: www.guttmacher.org/statecenter/spibs/spib_SADP.pdf Accessed: March 5, 2015.
16. Herbert, B. (1998). In America: Pregnancy and addiction. The New York Times. Available: www.nytimes.com/1998/06/11/opinion/in-america-pregnancy-and-addiction.html. Accessed: May 13, 2015.
17. Hesketh, S.R., Everitt, B.S., A handbook of statistical analyses using stata. 4th ed, 2006, CRC Press, Taylor & Francis Group, Boca Raton, FL.
18. Johnson v. State, 602 So. 2d 1288 (Fla. 1992).
19. Jones, H.E., O'Grady, K.E., Malfi, D., Tuten, M., Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. American Journal of Addictions 17:5 (2008), 372–386.
20. Kakko, J., Svanborg, K.D., Kreek, M.J., Heilig, M., 1-year retention and social function after. Buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial. Lancet 361:9358 (2003), 662–668.
21. Kandall, S.R., Substance and shadow: Women and addiction in the United States. 1996, Harvard University Press, Cambridge, MA.
22. Keeping Children and Families Safe Act (Public Law 108–36) Section 106(b)(2)(A)(ii).
23. Longest, K.C., Using Stata for quantitative analysis. 2nd ed, 2015, Sage, Thousand Oaks, CA.
24. Martin, C.E., Longinaker, N., Terplan, M., Recent trends in treatment admissions for prescription opioid abuse during pregnancy. Journal of Substance Abuse Treatment 48:1 (2015), 37–42.
25. Matusow, H., Dickman, S.L., Rich, J.D., Fong, C., Dumont, D.M., Hardin, C.,.. Rosenblum, A., Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes. Journal of Substance Abuse Treatment 44:5 (2013), 473–480.
26. Office of National Drug Control Policy. Health care brief: medication assisted treatment for opioid dependency. 2012 Available: www.whitehouse.gov/sites/default/files/ondcp/recovery/medication_assisted_treatment_9-21-20121.pdf Accessed: April 11, 2016.
27. Olsen, Y., Sharfstein, J.M., Confronting the stigma of opioid use disorder – and its treatment. Journal of the American Medical Association 311:14 (2014), 1393–1394.
28. Paltrow, L.M., Flavin, J., Arrests of and forced interventions on pregnant women in the United States, 1973–2005: Implications for women's legal status and public health. Journal of Health Politics, Policy, and Law 38:2 (2013), 299–343.
29. Patrick, S.W., Schumacher, R.E., Benneyworth, B.D., Krans, E.E., Mcallister, J.M., Davis, M.M., Neonatal abstinence syndrome and associated health care expenditures. Journal of the American Medical Association 307:18 (2012), 1934–1940.
30. Poland, M.L., Dombrowski, M.P., Ager, J.W., Sokol, R.J., Punishing pregnant drug users: Enhancing the flight from care. Drug and Alcohol Dependence 31:3 (1993), 199–203.
31. Public Chapter No 820 Senate Bill No 1391 (2014). Available: http://state.tn.us/sos/acts/108/pub/pc0820.pdf. Accessed: March 13, 2015.
32. Richards and Hornine v. Tennessee, 2005 Tenn. Crim. App. LEXIS 970 (Ten. 2005).
33. Rinaldo, S.G., Rinaldo, D.W., Availability without accessibility? State Medicaid coverage and authorization requirements for opioid dependence medications. 2013, American Society of Addiction Medicine Available: www.asam.org/docs/default-source/advocacy/aaam_implications-for-opioid-addiction-treatment_final Accessed: March 17, 2015.
34. Roberts, S.C., Nuru-Jeter, A., Women's perspectives on screening for alcohol and drug use in prenatal care. Womens Health Issues 20:3 (2010), 193–200.
35. Roberts, S.C., Nuru-Jeter, A., Universal screening for alcohol and drug use and racial disparities in child protective services reporting. Journal of Behavioral & Health Services ResearcJh 39:1 (2012), 3–16.
36. Rohan, A.J., Monk, C., Marder, K., Reame, N., Prenatal toxicology screening for substance abuse in research: Codes and consequences. Substance Abuse 32:3 (2011), 159–160.
37. Schempf, A.H., Strobino, D.M., Drug use and limited prenatal care: An examination of responsible barriers. American Journal of Obstetrics and Gynecology 200:4 (2009), 412.e1–412.e10.
38. Springer, D. (2014). Tennessee voices: Drug use in pregnancy is an epidemic. The Tennessean. Available: www.tennessean.com/story/opinion/contributors/2014/05/10/tennessee-voices-drug-use-pregnancy-epidemic/8914401/. Published May 9, 2014. Accessed: March 17, 2015.
39. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: National Findings. NHSDA Series H-46, HHS Publication No. (SMA) 13–4795, 2013, Author, Rockville, MD.
40. Svikis, D.S., Lee, J.H., Haug, N.A., Stitzer, M.L., Attendance incentives for outpatient treatment: Effects in methadone- and nonmethadone-maintained pregnant drug dependent women. Drug and Alcohol Dependence 48:1 (1997), 33–41.
41. Tennessee v. Hudson, Tenn. Crim. App. Lexis 496 (Ten. 2007).
42. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set – Admissions (TEDS-A), 2012. ICPSR35037-v1, 2012, Inter-university Consortium for Political and Social Research, Ann Arbor, MI [distributor], 2014-05-07.
43. Whitner v. South Carolina, 328 S.C. 1, 492 S.E.2d 777 (S.C. 1997).
44. World Health Organization (WHO). Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. 2009 Available: http://whqlibdoc.who.int/publications/2009/9789241547543_eng.pdf?ua=1 Accessed: March 19, 2015.